quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:03·156d
SECFiling
ProKidney Corp. logo

SEC Form EFFECT filed by ProKidney Corp.

PROK· ProKidney Corp.
Health Care
Original source

Companies

  • PROK
    ProKidney Corp.
    Health Care

Recent analyst ratings

  • Dec 16UpdateH.C. Wainwright$12.00
  • Jun 30UpdateBofA Securities$1.00
  • Sep 30UpdateJP Morgan-
  • Sep 10UpdateGuggenheim$6.00
  • Mar 7UpdateMorgan Stanley$3.00
  • Jan 2UpdateBofA Securities-

Related

  • SEC6d
    SEC Form DEFA14A filed by ProKidney Corp.
  • SEC6d
    SEC Form DEF 14A filed by ProKidney Corp.
  • PR29d
    ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
  • SEC36d
    SEC Form S-8 filed by ProKidney Corp.
  • SEC36d
    ProKidney Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • SEC36d
    SEC Form 10-K filed by ProKidney Corp.
  • PR36d
    ProKidney Reports Full Year 2025 Financial Results and Business Highlights
  • PR51d
    Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022